Life Insurance
Consensus Index

AI Consensus Fit Review

Transamerica Graded-Benefit Final Expense Insurance Fit Review

Transamerica is a good fit for most buyers who need Graded-Benefit Final Expense Insurance because of health conditions, but it is not a unanimous pick.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Transamerica is a good fit for most buyers who need Graded-Benefit Final Expense Insurance because of health conditions, but it is not a unanimous pick. Six of the seven platforms named Transamerica during the ranking stage, and five of those seven rated it a "good" fit while two rated it "mixed." The strongest reason to consider it is a clearly documented two-year graded structure: non-accidental death in the first two policy years pays 110% of premiums paid, then full face amount applies, with guaranteed level premiums and permanent whole life coverage. The main limitation is that graded coverage is capped at $25,000 in the cited materials, and current pricing is not publicly transparent.

Research Snapshot

FieldFinding
Platform mentions in ranking stage6 of 7 platforms (anthropic, deepseek, google, grok, kimi, perplexity)
Share of included platform responses85.7%
Average listed rank4.0
Best listed rank2
Relevant product/model/planTransamerica Graded FE Express Solution / Easy Solution graded-benefit whole life
Overall use-case fitGood, with material verification requirements
Research date2026-09-22

Why Transamerica Qualified for This Study

Questions This Section Answers

  • Is Transamerica a good choice for Graded-Benefit Final Expense Insurance?
  • Why did AI platforms rank Transamerica for buyers with health conditions?

Transamerica qualified because it offers a dedicated graded-benefit whole life product aimed at applicants who may not qualify for level-benefit final expense coverage, and because six of the seven platforms named it during ranking discovery. The ranking-stage product names included Easy Solution (Graded Benefit Whole Life), FE Express final expense whole life with a graded option, FE Express Solution Graded, and Transamerica Express Select graded or modified benefit tiers.

The company-owned evidence is the strongest part of the case. Transamerica's product portfolio identifies Easy Solution as graded nonparticipating whole life with level premiums to age 121, issue ages, and a $25,000 maximum [1]. The final expense specification sheet documents Easy Solution issue limits, premium duration, two-year graded death-benefit mechanics, policy-loan terms, and state/product-availability disclaimers [2]. The agent guide provides underwriting classifications and an illustrative congestive-heart-failure case qualifying for Easy Solution graded coverage [3].

Independent sources reinforce the fit. Reviewers describe Transamerica as having lenient underwriting for common senior health conditions that would disqualify applicants from traditional life insurance [4], and note that many conditions that would force a graded plan elsewhere can still qualify for level coverage with Transamerica [6]. One review states that clients with diabetes combined with COPD, insulin-dependent diabetes, or heart disease with stents can often qualify for level coverage [7].

This is a niche fit review, not a broad company review. It evaluates Transamerica only for the graded-benefit final expense use case. For the wider category, see the Graded-Benefit Final Expense Insurance consensus index.

The Product, Model, Plan, or Service Most Relevant to Graded-Benefit Final Expense Insurance

Questions This Section Answers

  • Which Transamerica plan should a buyer choose if they need graded-benefit final expense coverage?
  • Is Transamerica's Easy Solution the same as Graded FE Express Solution?

The most relevant product is Transamerica's graded-benefit whole life final expense coverage, marketed under overlapping names: Easy Solution (Graded Benefit Whole Life) and Graded FE Express Solution. The platforms did not agree on a single product name, and that naming conflict is itself a finding buyers must resolve before purchase.

Transamerica's press release identifies Transamerica Graded FE Express Solution (policy form number ICC23 TPWL15IC-0123) as a whole life insurance policy issued by Transamerica Life Insurance Company, Cedar Rapids, Iowa [8]. The same release states that FE Express provides permanent lifetime protection with guaranteed level premiums, up to $50,000 [11], and that Graded FE Express Solution is not guaranteed issue, with the underwriter reserving the right to request additional medical exams and data [12].

The older Easy Solution design is documented separately. The product portfolio identifies Easy Solution as nonparticipating whole life with a graded risk class, level premiums to age 121, issue ages 18–80, and a maximum issue amount of $25,000 [13]. The specification sheet shows a $1,000 minimum, $25,000 maximum, issue ages 18–80, and a New York issue-age range of 50–75 [14].

Platforms described the graded structure consistently even when product names differed. During the first two policy years, non-accidental death pays 110% of premiums paid, less any loan balance; accidental death pays the face amount; after two years, the face amount applies regardless of cause [14]. One platform described an alternative graded schedule for Easy Solution — Year 1 at 30%, Year 2 at 70%, Year 3 and later at 100% [24] — which conflicts with the 110%-of-premiums structure other platforms and the company specification sheet describe. Buyers should confirm the exact schedule in the policy illustration.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Transamerica's graded-benefit final expense coverage?
  • Does Transamerica's graded plan pay full benefits after two years?

Agreement was strong, though not unanimous, on four points.

First, the two-year graded structure. Platforms consistently reported that non-accidental death during the first two policy years is limited to 110% of premiums paid, and that full face amount applies after that period [25].

Second, guaranteed level premiums. Multiple platforms reported that premiums are guaranteed level and will not increase as long as premiums are paid on time [37].

Third, permanent coverage after the graded period. Platforms agreed the policy is whole life and that full unrestricted coverage begins after the two-year graded period without re-underwriting [27].

Fourth, no medical exam. Platforms agreed the product uses simplified-issue underwriting based on application answers and prescription records rather than a medical exam [49].

Platform agreement does not prove product quality. It shows that multiple independent retrieval systems surfaced the same documented mechanics from overlapping sources, several of which are company-owned.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Is Transamerica's graded final expense pricing competitive or expensive compared with other carriers?
  • How many complaints does Transamerica have, and does that affect final expense policies?

Disagreement and uncertainty clustered in five areas.

Product naming. Platforms used Easy Solution, Graded FE Express Solution, FE Express Solution graded option, and Express Select graded or modified tiers. Public materials indicate multiple product generations and policy forms, and it is unclear whether Easy Solution and FE Express graded are distinct products or the same product under different marketing names.

Pricing direction. One platform reported that Transamerica's rates are competitive, though they tend to run slightly higher than Mutual of Omaha [56]. Another reported sample premiums among the lowest in independent comparisons — approximately $40.77 per month for a 65-year-old female and $54 per month for a 65-year-old male for $10,000 of coverage [58]. A third reported that the graded plan can be significantly more expensive compared to similar offerings from other providers [60]. These are not reconcilable from the supplied evidence.

Complaint and litigation history. One platform reported an NAIC individual-life complaint index roughly four times the industry median, plus parent-company class-action settlements on universal life lines ($57 million cost-of-insurance settlement, $88 million Thompson settlement) [58]. No direct litigation was found specific to final expense products, but the same legal entity is involved. Other platforms did not raise complaint data at all.

Rider availability. The older Easy Solution specification states that no riders are available on that policy [61], while newer FE Express materials describe an optional concierge funeral-planning benefit [62]. The difference may reflect different product generations or forms.

Graded schedule. As noted above, one platform described a 30%/70%/100% graded schedule [66] while the company specification sheet and most platforms describe 110% of premiums paid [61].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What health conditions can still qualify for Transamerica's graded final expense coverage?
  • Does Transamerica's graded plan cover accidental death at full benefit from day one?

The features most relevant to a health-impaired buyer are underwriting flexibility, the early-year benefit structure, and the digital application.

Underwriting flexibility. The agent guide gives an example in which an applicant taking medication for congestive heart failure qualified for the graded Easy Solution product, while increased activity could change the underwriting result to an immediate product [69]. The same guide lists many conditions with differing outcomes, including congestive heart failure and COPD as standard in the cited guide, while hospice, dementia, and several other conditions are shown as declines [69]. Eligibility is condition-specific and may differ by age, medications, activity, state, and current underwriting rules.

One independent review reported that applicants taking any antipsychotic medication are automatically placed in the graded plan regardless of the reason for the prescription, including off-label use for insomnia, anxiety, or depression [70]. This is a single-source, platform-reported claim and should be verified directly with the carrier.

Early-year benefit structure. Accidental death during the first two policy years receives the face amount; death from another cause is limited to 110% of premiums paid, less any loan balance [74]. After the first two years, the face amount applies regardless of cause, less any loan balance [74].

Digital application. Transamerica's FE Express marketing describes a streamlined digital application, instant decisions, electronic delivery, and an optional concierge funeral-planning benefit [79]. Company materials state FE Express Solution can be purchased in as few as 10 minutes without a medical exam [80], and that there is no waiting period to get approved for FE Express [82]. These are company and agent-directed marketing claims; actual delivery timing should be verified.

Coverage limits. The cited Easy Solution materials show a $1,000 minimum, $25,000 maximum, and issue ages 18–80, with a New York issue-age range of 50–75 [74]. Independent reviews report graded policies capped at $25,000 and a graded option available up to age 80 [83].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Transamerica's graded final expense plan cost per month?
  • Are there policy fees or loan interest charges on Transamerica's graded final expense policy?

Personalized premiums were not publicly verifiable from the reviewed sources, and pricing confidence is low. Premiums are subject to underwriting, age, sex, tobacco status, state, face amount, and product form.

The only concrete cost figures in the supplied evidence are sample quotes from independent reviews: approximately $40.77 per month for a 65-year-old female and $54 per month for a 65-year-old male for $10,000 of coverage [86], and $334.63 per month for an 80-year-old male for $10,000 of graded coverage, or $4,015.56 per year [88]. These are platform-reported samples, not carrier-published rates, and they vary widely by age.

Documented older Easy Solution policy fees were $60 annually for face amounts below $5,000 and $42 annually for face amounts of $5,000 or more; these producer materials are dated September 2022 and may not apply to the current FE Express form [90]. A policy loan may accrue interest at a variable rate not exceeding 8% under the cited older specification [90]. Policy loans reduce benefits and may create additional interest costs.

Contract terms documented in the cited materials: the graded limitation applies during the first two policy years under the documented Easy Solution form; after two years, the death benefit is the face amount less any loan balance, regardless of cause [90]. Policy availability, forms, riders, underwriting, and terms may vary by state [90]. No current public evidence was found establishing a guaranteed conversion from graded to level benefits; the buyer should not assume one.

Best Suited For

Questions This Section Answers

  • Who is Transamerica's graded-benefit final expense plan best for?
  • What coverage amount and age range fit Transamerica's graded final expense product?

Transamerica's graded product is best suited to applicants with health conditions that may lead to graded rather than immediate underwriting, who want permanent coverage with level premiums and accept reduced non-accidental benefits during the first two policy years.

Specifically: applicants with health conditions that may lead to graded rather than immediate underwriting; buyers seeking permanent coverage with level premiums to age 121; and buyers needing approximately $1,000 to $25,000 of final-expense coverage who accept reduced non-accidental benefits during the first two policy years [92]. Platforms also flagged buyers who value fast digital approval and want to avoid medical exams [94], and consumers who prioritize accidental death coverage, which pays full benefit from day one even during the graded period [97].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Transamerica for graded-benefit final expense insurance?
  • Is Transamerica's graded final expense plan available in New York?

Transamerica is probably not the best fit for applicants who may qualify for an immediate or level-benefit policy elsewhere, applicants needing full natural-death coverage during the first two policy years, and applicants needing more than $25,000 of graded coverage or transparent online rate quotes [99].

Additional exclusions from the supplied evidence: the graded FE Express Solution is not available in New York [101]. The product is not guaranteed issue, and the underwriter reserves the right to request additional medical exams and data [104]. Some applicants with severe or recent conditions may still be declined rather than placed into graded coverage [106]. Buyers who prioritize an exceptionally low complaint record or clean litigation history above low premium may also want to look elsewhere [107].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Transamerica if the buyer needs more than $25,000 of graded coverage?
  • When should a buyer choose a guaranteed-issue policy instead of Transamerica's graded plan?

Another option may be better in several defined situations.

If a competing carrier offers immediate or level-benefit coverage at a similar premium after reviewing the applicant's actual health history, that is generally preferable to graded coverage [109]. If the buyer needs more than $25,000 of coverage under the graded tier, the documented Easy Solution maximum will not fit [111]. If the buyer requires a guaranteed-issue policy and accepts its typically more restrictive economics and benefit structure, a true guaranteed-issue product may be a better match [109]. If the buyer needs a limited-pay design, such as premiums paid for a fixed number of years rather than premiums to age 121, Transamerica's documented design does not provide it [109].

Platforms also suggested comparing against Mutual of Omaha Living Promise for a broader set of published riders and transparent feature comparison [114], and against carriers with lower NAIC complaint indices when service reputation matters more than premium [116]. One review advised that if only being offered the graded plan, buyers should shop around before committing [118].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Transamerica before signing a graded final expense contract?
  • Which policy form and issuing company will appear on the Transamerica graded policy?

The verification list below consolidates the questions platforms flagged. None of these can be answered from public materials alone.

  • Which exact policy form and issuing company will appear on the application and policy in the buyer's state? [119]
  • What is the exact first-two-year benefit for natural death, accidental death, suicide, and other exclusions? [120]
  • Does the current policy pay 110% of premiums, another amount, or a different graded schedule? [120]
  • What is the fully loaded premium, including policy fees, payment-mode charges, and any selected benefits or riders? [120]
  • Is the premium guaranteed level for the entire policy duration, and what happens if a payment is missed? [123]
  • What are the current issue-age and face-amount limits in the buyer's state? [120]
  • Could the applicant qualify for Transamerica's immediate or level-benefit tier instead of graded coverage? [125]
  • What medical conditions, medications, recent hospitalizations, hospice status, or functional limitations would cause a decline? [126]
  • Are there current riders or concierge services, and do they reduce the death benefit or impose separate limitations? [120]
  • How do policy loans, withdrawals, lapse, reinstatement, and surrender affect coverage and cash value? [120]
  • Is there any free-look period, and what are the cancellation and refund rules under state law? [120]
  • Can an independent agent compare the quoted Transamerica premium and benefit schedule with at least several competing graded and immediate-benefit carriers? [129]

Final AI Consensus Verdict

Transamerica is a good fit for graded-benefit final expense insurance, with material verification requirements. Five of the seven platforms rated it a good fit; two rated it mixed. The documented Easy Solution design directly addresses the target buyer by offering graded underwriting, permanent whole life coverage, level premiums to age 121, and full face-amount benefits after the first two policy years [130].

The principal tradeoffs are the substantial early natural-death limitation, the $25,000 graded maximum in the cited materials, incomplete current public pricing, and uncertainty over whether newer FE Express terms match the older Easy Solution specification [130]. Platform-reported complaint and litigation data on other product lines adds a service-reputation caveat that some buyers will weigh heavily [133].

Buyers should obtain a state-specific illustration with exact graded terms, confirm the policy form and issuing entity, and compare the quoted premium against at least several competing graded and immediate-benefit carriers before committing.

How This Review Was Produced

This review was produced from seven AI platform responses to a single buyer-intent prompt about graded-benefit final expense insurance for applicants with health conditions. Six of the seven platforms named Transamerica during the ranking stage. Each platform supplied fit assessments, product findings, pricing notes, limitations, and verification questions. The research date is 2026-09-22. Platform-reported research dates were 2026-09-23 and are provenance metadata only; they do not independently prove freshness.

All platform responses were treated as platform-reported evidence, not independently verified facts. Company-owned sources were distinguished from independent and unclear-ownership sources. Where platforms conflicted on product names, pricing direction, graded schedules, or complaint data, the conflict is disclosed rather than resolved.

Methodology Limitations

Several limitations apply. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Platform-reported research dates differ from the authoritative run date. The reviewed evidence does not independently verify current financial-strength ratings, claims outcomes, complaint ratios, or comparative pricing for this product. The detailed graded-benefit schedule located is for Easy Solution and is dated September 2022; it may not govern the newer FE Express graded form. Public sources do not provide a current nationwide premium table for the target buyer profile. State-specific availability and policy forms may differ, especially in New York. One platform's official-site retrieval failed, and no failed fetch was used as a verified domain key. Platform agreement does not prove product quality.

Sources

Company-Owned Sources

  • Transamerica Simplifies Final Expense Insurance for Consumers and Agents: https://www.transamerica.com/press-release/transamerica-simplifies-final-expense-insurance-consumers-and-agents
  • Additional AI research evidence134 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c2
    3. AI research evidence record openai:c3
    4. AI research evidence record anthropic:6-15
    5. AI research evidence record anthropic:15-14
    6. AI research evidence record anthropic:15-15
    7. AI research evidence record anthropic:20-17
    8. AI research evidence record anthropic:2-6
    9. AI research evidence record anthropic:10-1
    10. AI research evidence record anthropic:22-7
    11. AI research evidence record anthropic:22-9
    12. AI research evidence record anthropic:10-5
    13. AI research evidence record openai:c1
    14. AI research evidence record openai:c2
    15. AI research evidence record anthropic:1-1
    16. AI research evidence record anthropic:1-2
    17. AI research evidence record anthropic:4-1
    18. AI research evidence record anthropic:4-2
    19. AI research evidence record anthropic:19-6
    20. AI research evidence record anthropic:19-7
    21. AI research evidence record anthropic:19-8
    22. AI research evidence record perplexity:c7
    23. AI research evidence record google:2.1.2
    24. AI research evidence record grok:1
    25. AI research evidence record openai:c2
    26. AI research evidence record anthropic:1-1
    27. AI research evidence record anthropic:1-2
    28. AI research evidence record anthropic:4-1
    29. AI research evidence record anthropic:4-2
    30. AI research evidence record anthropic:19-6
    31. AI research evidence record anthropic:19-7
    32. AI research evidence record anthropic:19-8
    33. AI research evidence record perplexity:c7
    34. AI research evidence record google:2.1.2
    35. AI research evidence record deepseek:c2
    36. AI research evidence record kimi:consumeradviser-transamerica-2026
    37. AI research evidence record anthropic:4-3
    38. AI research evidence record anthropic:4-4
    39. AI research evidence record anthropic:22-1
    40. AI research evidence record anthropic:22-9
    41. AI research evidence record deepseek:c1
    42. AI research evidence record grok:1
    43. AI research evidence record anthropic:28-2
    44. AI research evidence record anthropic:28-9
    45. AI research evidence record perplexity:c3
    46. AI research evidence record perplexity:c5
    47. AI research evidence record perplexity:c9
    48. AI research evidence record perplexity:c14
    49. AI research evidence record anthropic:3-9
    50. AI research evidence record anthropic:30-5
    51. AI research evidence record anthropic:33-2
    52. AI research evidence record anthropic:11-1
    53. AI research evidence record grok:0
    54. AI research evidence record perplexity:c1
    55. AI research evidence record deepseek:c3
    56. AI research evidence record anthropic:23-2
    57. AI research evidence record anthropic:23-4
    58. AI research evidence record deepseek:c2
    59. AI research evidence record kimi:consumeradviser-transamerica-2026
    60. AI research evidence record anthropic:21-9
    61. AI research evidence record openai:c2
    62. AI research evidence record openai:c4
    63. AI research evidence record anthropic:5-5
    64. AI research evidence record perplexity:c3
    65. AI research evidence record perplexity:c9
    66. AI research evidence record grok:1
    67. AI research evidence record perplexity:c7
    68. AI research evidence record google:2.1.2
    69. AI research evidence record openai:c3
    70. AI research evidence record anthropic:15-4
    71. AI research evidence record anthropic:15-5
    72. AI research evidence record anthropic:15-6
    73. AI research evidence record anthropic:15-7
    74. AI research evidence record openai:c2
    75. AI research evidence record anthropic:1-1
    76. AI research evidence record anthropic:5-2
    77. AI research evidence record anthropic:1-2
    78. AI research evidence record anthropic:19-8
    79. AI research evidence record openai:c4
    80. AI research evidence record anthropic:3-9
    81. AI research evidence record anthropic:22-8
    82. AI research evidence record anthropic:3-11
    83. AI research evidence record anthropic:19-1
    84. AI research evidence record anthropic:12-3
    85. AI research evidence record anthropic:30-3
    86. AI research evidence record deepseek:c2
    87. AI research evidence record kimi:consumeradviser-transamerica-2026
    88. AI research evidence record anthropic:15-1
    89. AI research evidence record anthropic:15-2
    90. AI research evidence record openai:c2
    91. AI research evidence record anthropic:30-9
    92. AI research evidence record openai:c1
    93. AI research evidence record openai:c2
    94. AI research evidence record anthropic:3-9
    95. AI research evidence record anthropic:22-8
    96. AI research evidence record deepseek:c2
    97. AI research evidence record anthropic:5-2
    98. AI research evidence record grok:1
    99. AI research evidence record openai:c1
    100. AI research evidence record openai:c2
    101. AI research evidence record anthropic:10-6
    102. AI research evidence record perplexity:c7
    103. AI research evidence record anthropic:30-9
    104. AI research evidence record anthropic:10-5
    105. AI research evidence record anthropic:33-4
    106. AI research evidence record openai:c3
    107. AI research evidence record deepseek:c2
    108. AI research evidence record kimi:consumeradviser-transamerica-2026
    109. AI research evidence record openai:c1
    110. AI research evidence record anthropic:15-15
    111. AI research evidence record openai:c2
    112. AI research evidence record anthropic:19-1
    113. AI research evidence record anthropic:10-5
    114. AI research evidence record deepseek:c3
    115. AI research evidence record grok:3
    116. AI research evidence record deepseek:c2
    117. AI research evidence record kimi:consumeradviser-transamerica-2026
    118. AI research evidence record anthropic:15-3
    119. AI research evidence record openai:c1
    120. AI research evidence record openai:c2
    121. AI research evidence record perplexity:c7
    122. AI research evidence record grok:1
    123. AI research evidence record anthropic:4-3
    124. AI research evidence record anthropic:19-1
    125. AI research evidence record anthropic:15-15
    126. AI research evidence record openai:c3
    127. AI research evidence record openai:c4
    128. AI research evidence record anthropic:5-5
    129. AI research evidence record anthropic:15-3
    130. AI research evidence record openai:c1
    131. AI research evidence record openai:c2
    132. AI research evidence record openai:c4
    133. AI research evidence record deepseek:c2
    134. AI research evidence record kimi:consumeradviser-transamerica-2026

Independent Sources

Other Sources

  • Additional AI research evidence134 records
    1. AI research evidence record openai:c1
    2. AI research evidence record openai:c2
    3. AI research evidence record openai:c3
    4. AI research evidence record anthropic:6-15
    5. AI research evidence record anthropic:15-14
    6. AI research evidence record anthropic:15-15
    7. AI research evidence record anthropic:20-17
    8. AI research evidence record anthropic:2-6
    9. AI research evidence record anthropic:10-1
    10. AI research evidence record anthropic:22-7
    11. AI research evidence record anthropic:22-9
    12. AI research evidence record anthropic:10-5
    13. AI research evidence record openai:c1
    14. AI research evidence record openai:c2
    15. AI research evidence record anthropic:1-1
    16. AI research evidence record anthropic:1-2
    17. AI research evidence record anthropic:4-1
    18. AI research evidence record anthropic:4-2
    19. AI research evidence record anthropic:19-6
    20. AI research evidence record anthropic:19-7
    21. AI research evidence record anthropic:19-8
    22. AI research evidence record perplexity:c7
    23. AI research evidence record google:2.1.2
    24. AI research evidence record grok:1
    25. AI research evidence record openai:c2
    26. AI research evidence record anthropic:1-1
    27. AI research evidence record anthropic:1-2
    28. AI research evidence record anthropic:4-1
    29. AI research evidence record anthropic:4-2
    30. AI research evidence record anthropic:19-6
    31. AI research evidence record anthropic:19-7
    32. AI research evidence record anthropic:19-8
    33. AI research evidence record perplexity:c7
    34. AI research evidence record google:2.1.2
    35. AI research evidence record deepseek:c2
    36. AI research evidence record kimi:consumeradviser-transamerica-2026
    37. AI research evidence record anthropic:4-3
    38. AI research evidence record anthropic:4-4
    39. AI research evidence record anthropic:22-1
    40. AI research evidence record anthropic:22-9
    41. AI research evidence record deepseek:c1
    42. AI research evidence record grok:1
    43. AI research evidence record anthropic:28-2
    44. AI research evidence record anthropic:28-9
    45. AI research evidence record perplexity:c3
    46. AI research evidence record perplexity:c5
    47. AI research evidence record perplexity:c9
    48. AI research evidence record perplexity:c14
    49. AI research evidence record anthropic:3-9
    50. AI research evidence record anthropic:30-5
    51. AI research evidence record anthropic:33-2
    52. AI research evidence record anthropic:11-1
    53. AI research evidence record grok:0
    54. AI research evidence record perplexity:c1
    55. AI research evidence record deepseek:c3
    56. AI research evidence record anthropic:23-2
    57. AI research evidence record anthropic:23-4
    58. AI research evidence record deepseek:c2
    59. AI research evidence record kimi:consumeradviser-transamerica-2026
    60. AI research evidence record anthropic:21-9
    61. AI research evidence record openai:c2
    62. AI research evidence record openai:c4
    63. AI research evidence record anthropic:5-5
    64. AI research evidence record perplexity:c3
    65. AI research evidence record perplexity:c9
    66. AI research evidence record grok:1
    67. AI research evidence record perplexity:c7
    68. AI research evidence record google:2.1.2
    69. AI research evidence record openai:c3
    70. AI research evidence record anthropic:15-4
    71. AI research evidence record anthropic:15-5
    72. AI research evidence record anthropic:15-6
    73. AI research evidence record anthropic:15-7
    74. AI research evidence record openai:c2
    75. AI research evidence record anthropic:1-1
    76. AI research evidence record anthropic:5-2
    77. AI research evidence record anthropic:1-2
    78. AI research evidence record anthropic:19-8
    79. AI research evidence record openai:c4
    80. AI research evidence record anthropic:3-9
    81. AI research evidence record anthropic:22-8
    82. AI research evidence record anthropic:3-11
    83. AI research evidence record anthropic:19-1
    84. AI research evidence record anthropic:12-3
    85. AI research evidence record anthropic:30-3
    86. AI research evidence record deepseek:c2
    87. AI research evidence record kimi:consumeradviser-transamerica-2026
    88. AI research evidence record anthropic:15-1
    89. AI research evidence record anthropic:15-2
    90. AI research evidence record openai:c2
    91. AI research evidence record anthropic:30-9
    92. AI research evidence record openai:c1
    93. AI research evidence record openai:c2
    94. AI research evidence record anthropic:3-9
    95. AI research evidence record anthropic:22-8
    96. AI research evidence record deepseek:c2
    97. AI research evidence record anthropic:5-2
    98. AI research evidence record grok:1
    99. AI research evidence record openai:c1
    100. AI research evidence record openai:c2
    101. AI research evidence record anthropic:10-6
    102. AI research evidence record perplexity:c7
    103. AI research evidence record anthropic:30-9
    104. AI research evidence record anthropic:10-5
    105. AI research evidence record anthropic:33-4
    106. AI research evidence record openai:c3
    107. AI research evidence record deepseek:c2
    108. AI research evidence record kimi:consumeradviser-transamerica-2026
    109. AI research evidence record openai:c1
    110. AI research evidence record anthropic:15-15
    111. AI research evidence record openai:c2
    112. AI research evidence record anthropic:19-1
    113. AI research evidence record anthropic:10-5
    114. AI research evidence record deepseek:c3
    115. AI research evidence record grok:3
    116. AI research evidence record deepseek:c2
    117. AI research evidence record kimi:consumeradviser-transamerica-2026
    118. AI research evidence record anthropic:15-3
    119. AI research evidence record openai:c1
    120. AI research evidence record openai:c2
    121. AI research evidence record perplexity:c7
    122. AI research evidence record grok:1
    123. AI research evidence record anthropic:4-3
    124. AI research evidence record anthropic:19-1
    125. AI research evidence record anthropic:15-15
    126. AI research evidence record openai:c3
    127. AI research evidence record openai:c4
    128. AI research evidence record anthropic:5-5
    129. AI research evidence record anthropic:15-3
    130. AI research evidence record openai:c1
    131. AI research evidence record openai:c2
    132. AI research evidence record openai:c4
    133. AI research evidence record deepseek:c2
    134. AI research evidence record kimi:consumeradviser-transamerica-2026

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
42
Ranking mentions
6 of 7
Platform share
86%
Final consensus rank
#2

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

28 independent · 7 company-owned · 7 unclear

Evidence support

19 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

8f0f845c72543e8313e1a046d13793384bcec1f68fcc378d2c87c385f981b70a